Literature DB >> 21732772

The recurrent nevus phenomenon: a history of challenge, controversy, and discovery.

John C Fox1, Jon A Reed, Christopher R Shea.   

Abstract

CONTEXT: The diagnosis of recurrent nevus poses a potential challenge to practicing pathologists. Although most recurrent nevi show uniform microscopic findings and pose no great diagnostic difficulty, a few cases exhibit some histopathologic features similar to, and in some cases indistinguishable from, melanoma. Historically, the term pseudomelanoma has been used in the literature to describe such recurrent nevi, although this label has the potential for confusion and is no longer the favored term for recurrent pigmented melanocytic nevi.
OBJECTIVE: To describe historical, histopathologic, and immunohistochemical features of recurrent pigmented melanocytic nevi and to review briefly the literature surrounding the mechanism of recurrence. DATA SOURCES: Published peer-reviewed literature and the authors' personal experience.
CONCLUSIONS: Recognition of the histopathologic pattern of recurrent nevi leads the pathologist to the correct diagnosis in most cases; however, in particularly challenging specimens or in circumstances in which there is insufficient clinical history, immunohistochemical studies have proved helpful in distinguishing recurrent nevi from melanoma.

Entities:  

Mesh:

Year:  2011        PMID: 21732772     DOI: 10.5858/2010-0429-RAR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

Review 1.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

Review 2.  Recognizing Histopathological Simulators of Melanoma to Avoid Misdiagnosis.

Authors:  Sara Waqar; Sheeba George; Wilford Jean-Baptiste; Amina Yusuf Ali; Bithaiah Inyang; Feeba Sam Koshy; Kitty George; Prakar Poudel; Roopa Chalasani; Mastiyage R Goonathilake; Lubna Mohammed
Journal:  Cureus       Date:  2022-06-20

3.  Inactivation of the Hippo tumor suppressor pathway promotes melanoma.

Authors:  Marc A Vittoria; Nathan Kingston; Kristyna Kotynkova; Eric Xia; Rui Hong; Lee Huang; Shayna McDonald; Andrew Tilston-Lunel; Revati Darp; Joshua D Campbell; Deborah Lang; Xiaowei Xu; Craig J Ceol; Xaralabos Varelas; Neil J Ganem
Journal:  Nat Commun       Date:  2022-06-29       Impact factor: 17.694

Review 4.  Histologic mimics of malignant melanoma.

Authors:  Caroline Bsirini; Bruce R Smoller
Journal:  Singapore Med J       Date:  2018-05-18       Impact factor: 1.858

Review 5.  Investigation of cAMP microdomains as a path to novel cancer diagnostics.

Authors:  Garrett Desman; Caren Waintraub; Jonathan H Zippin
Journal:  Biochim Biophys Acta       Date:  2014-09-07

6.  Recurrence of Dysplastic Nevi Is Strongly Associated with Extension of the Lesions to the Lateral Margins and into the Deep Margins through the Hair Follicles in the Original Shave Removal Specimens.

Authors:  Amin Maghari
Journal:  Dermatol Res Pract       Date:  2016-09-28

7.  The recurrent nevus phenomenon.

Authors:  Rafaella Daboit Castagna; Juliana Mazzoleni Stramari; Raíssa Massaia Londero Chemello
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

8.  "Pseudotumors" in Dermatology.

Authors:  Vishal Gaurav; Chander Grover
Journal:  Indian Dermatol Online J       Date:  2022-03-03

9.  Sclerosing Melanocytic Lesions (sclerosing Melanomas with Nevoid Features and Sclerosing Nevi with Pseudomelanomatous Features) - An Analysis of 90 Lesions.

Authors:  Biljana Grcar-Kuzmanov; Emanuela Bostjancic; Juan Antonio Contreras Bandres; Joze Pizem
Journal:  Radiol Oncol       Date:  2018-01-24       Impact factor: 4.214

10.  Non-invasive optical biopsy by multiphoton microscopy identifies the live morphology of common melanocytic nevi.

Authors:  Griffin Lentsch; Manuel Valdebran; Inga Saknite; Janellen Smith; Kenneth G Linden; Karsten König; Ronald J Barr; Ronald M Harris; Bruce J Tromberg; Anand K Ganesan; Christopher B Zachary; Kristen M Kelly; Mihaela Balu
Journal:  Pigment Cell Melanoma Res       Date:  2020-06-17       Impact factor: 4.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.